Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
September 15, 2017FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia4 minutesPlayFDA D.I.S.C.O.: A new treatment for acute myelogenous leukemiaFDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia....moreShareView all episodesBy U.S. Food and Drug Administration, Center for Drug Evaluation and Research4.41414 ratingsSeptember 15, 2017FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia4 minutesPlayFDA D.I.S.C.O.: A new treatment for acute myelogenous leukemiaFDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia....more
FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemiaFDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia.
September 15, 2017FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia4 minutesPlayFDA D.I.S.C.O.: A new treatment for acute myelogenous leukemiaFDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia....more
FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemiaFDA medical oncologists discuss the Aug. 3, 2017, approval of Vyxeos for treatment of acute myelogenous leukemia.